PlainRecalls
FDA Devices Moderate Class II Ongoing

BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.

Reported: January 11, 2023 Initiated: November 18, 2022 #Z-0777-2023

Product Description

BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.

Reason for Recall

Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212

Details

Recalling Firm
Beckman Coulter, Inc.
Units Affected
3657 units
Distribution
US and Canada, Brazil, Korea, Mexico, Puerto Rico, Taiwan
Location
Miami, FL

Frequently Asked Questions

What product was recalled?
BECKMAN COULTER IRISpec CA/CB/CC control, REF 900-7211, For in vitro diagnostic use only.. Recalled by Beckman Coulter, Inc.. Units affected: 3657 units.
Why was this product recalled?
Beckman Coulter has become aware of an increase in customer complaints generated for intermittent IRISpec CB glucose control false positive results when used in conjunction with iChemVelocity Urine Chemistry Strips PN 800-7212
Which agency issued this recall?
This recall was issued by the FDA Devices on January 11, 2023. Severity: Moderate. Recall number: Z-0777-2023.